Artificial Intelligence

Cleveland expands its AI security robot program, citing reduced crime. But as other cities watch, questions of cost, privacy, and effectiveness emerge.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

After a 600%+ stock surge and an abrupt SEC trading halt, Charming Medical is now facing class action lawsuits alleging a social media manipulation scheme.

iQSTEL caps a transformational year with a NASDAQ uplist, record revenue, and a strategic pivot to Fintech and Cybersecurity, eyeing a $1B future.

A Korean AI startup raised $854K for a gesture-control ring, betting its enterprise-grade tech can unlock the future of post-touch computing.

Early data shows QurAlis' QRL-101 successfully engaged its intended target in ALS patients, a key step for a novel drug aimed at quelling neuronal storm.

Gogo has launched its anticipated 5G network for business jets, promising a new era of speed. But can its regional advantage hold against global satellite rivals?

Traini's new generative AI collar claims to translate dog emotions into human language. But does the science back up this multi-million dollar bet?

AXT, Inc. secured $100M in a volatile public offering, betting big on its China-based production of indium phosphide for the booming AI and 5G markets.

Bluejay Diagnostics can now make 9 million sepsis tests. This manufacturing win is huge, but the real race for FDA approval has only just begun.

A deepened strategic alliance sees mobility tech provider ECARX invest in Lotus, aiming to accelerate the future of the intelligent, AI-driven cockpit.

After a 130% stock surge, Tower Semiconductor faces investors to justify its high valuation and prove its AI-driven growth story is just beginning.

Crypto exchange Ourbit concludes a massive campaign, leveraging gamification and an NFT with a buyback guarantee to drive $2.2B in volume and redefine loyalty.

Struggling fashion e-commerce firm MOGU Inc. makes a surprising $14.2M investment in an unnamed AI company, signaling a bold bet on China's tech future.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.

A $10.5M investment gives Enduring Wealth Capital near-majority control of Cango, accelerating its pivot to AI and raising questions about its future.

With a massive IDR 200 billion capital boost from LDA Capital, Indonesian tech firm NANO is set to execute nearly IDR 5 trillion in contracts.

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

AEON partners with United Stables, enabling its $U stablecoin for payments at 50M merchants and powering a new frontier of autonomous AI transactions.